Skip to main content
Erschienen in: Hereditary Cancer in Clinical Practice 1/2018

Open Access 01.12.2018 | Retraction Note

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

verfasst von: Pål Møller, Eivind Hovig

Erschienen in: Hereditary Cancer in Clinical Practice | Ausgabe 1/2018

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found at http://​dx.​doi.​org/​10.​1186/​s13053-017-0080-y.

Retraction

This article [1] has been retracted at the request of the authors. Upon re-review of the data, the authors identified coding errors in this study. Due to an error in the SQL query, the conclusions drawn in the article are incorrect. A re-examination of the data shows that there is no association between familial breast cancer and the BRCA2 variant c.68–7 T > A. Another recent study suggests that the variant is not pathogenic [2]. All authors agree to this retraction.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN
Literatur
2.
Zurück zum Zitat Colombo M, et al. The BRCA2 c.68-7T > a variant is not pathogenic: a model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729–41.CrossRefPubMed Colombo M, et al. The BRCA2 c.68-7T > a variant is not pathogenic: a model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729–41.CrossRefPubMed
Metadaten
Titel
Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer
verfasst von
Pål Møller
Eivind Hovig
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Hereditary Cancer in Clinical Practice / Ausgabe 1/2018
Elektronische ISSN: 1897-4287
DOI
https://doi.org/10.1186/s13053-018-0093-1

Weitere Artikel der Ausgabe 1/2018

Hereditary Cancer in Clinical Practice 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.